RESTORx DIABETIC SUPPORT
SUPPORTING GLUCOSE CONTROL WITH METFORMIN
Metformin has become first-line therapy for patients with type 2 diabetes - the only anti-diabetic agent to reduce macrovascular outcomes1
At least 45% of individuals with type 2 diabetes fail to achieve adequate glycemic control. A major contributing factor is poor adherence.1
Interventions improving adherence requires a multifaceted approach.
A recent study recommending interventions targeting medication side effects might be of particular value.1
Diabetic Support contains natural ingredients to reduce the impact of side effects, which contributes to improving medication adherence and treatment results.
SOLAL® RestorX Diabetic Support has 3 hero ingredients, in their optimal doses, to restore, reduce, enhance and oppose side effects cause by blood-sugar lowering medication.
Loss of appetite
Nausea and vomiting
Increased cardiovascular disease risk
High blood pressure
Congestive heart failure
Muscular fatigue, joint and muscle aches, rhabdomyolysis
Irregular heart beat
RESTORx DIABETIC SUPPORT
To be used in conjunction with prescribed blood-sugar lowering medicines, to reduce their side effects by restoring medication-induced nutrient deficiencies.
|Each Capsule Contains||Amount Available in RESTORx Diabetic Support|
|Co-Enzyme Q10||100 mg|
|Vitamin B1 (Thiamine monohydrate)||10 mg|
|Vitamin B12 (Methylcobalamin form)||100 μg|
|Folate (L-5-Methyltetrahydrofolate calcium)||500 μg|
|Chromium (Chromium polynicotinate)||50 μg|
|Vitamin B6 (Pyridoxine hydrochloride)||30 mg|
|Vitamin D3||1000 IU|
DOSE: Adults: Take one capsule daily after a meal.
For full prescribing information, refer to the package insert/product information approved by the regulatory authority. This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use.References:
- 1. Rojas L.B., and Gomes, M.B. 2013. Metformin: an old but still the best treatment for type 2 diabetes. Diabetology & Metabolic Syndrome. 5(6):1-15.
- 2. Sing R, Teel C, et al. 2016. Fatigue in Type 2 Diabetes: Impact on quality of life and predictors. PLoS One, 1-13.
- 3. Vitamin Deficiencies in People With Diabetes: the Supplements You Need | Diabetes Health. Access on August 2018. Available on https://www.diabeteshealth.com/vitamin-deficiencies-in-people-with-diabetes-the-supplements-you-need/
- 4. Heyman A, Lavalle J.B. et al. 2010. An integrative medicine approach to managing nutrient depletions in the cardiometabolic patient. JMH. 7(2):145-158.
- 5. Kibirige D and Mwebaze R. 2013. Vitamin B12 deficiency among patients with diabetes mellitus: Is routine screening and supplementation justified? Journal of Diabetes and Metabolic Disorders. 12(17):1-6.
- 6. Green R. 2017. Vitamin B12 deficiency from the perspective of a practicing hematologist. Blood. 129(9): 2603-2611
- 7. Adenosylcobalamin. Accessed on August 18. Available from B12-Vitamin.org
- 8. Ganguly P and Alam S.F. 2015. Role of homcysteine in the development of cardiovascular disease. Nutrition Journal. 14(6):1-10.
- 9. Blom H.J. and Smulders Y. 2011. Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. J Inherit Metab Dis. 34:75–81.
- 10. Lentz S. 2001. Does Homocysteine Promote Atherosclerosis? Arterioscler Thromb Vasc Biol. 21:1385-1386.
- 11. Alam A. and Rahman M. 2014. Mitochondrial dysfunction in obesity: potential benefit and mechanism of Coenzyme Q10 supplementation in metabolic syndrome. Journal of Diabetes and Metabolic Disorders. 13(60):1-11.
- 12. Molyneux, S.L.,Young, J.M. et al. 2018. Coenzyme Q10: Is There a Clinical Role and a Case for Measurement? Clin Biochem Rev. 29:71-82.
- 13. Gaby A.R. 1996. The Role of Coenzyme Q10 in Clinical Medicine: Part II. Cardiovascular Disease, Hypertension, Diabetes Mellitus and Infertility. Alternative Medicine Review. 1(3):1-8.
- 14. Zahedi, H., Eghtesadi, S. et al. 2014. Effects of CoQ10 Supplementation on Lipid Profiles and Glycemic Control in Patients with Type 2 Diabetes: a randomized, double blind, placebo-controlled trial. Journal of Diabetes & Metabolic Disorders. 13(81):1-8.